Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study.
about
Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trialElevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjectsHomocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementationDistribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American men: the Third National Health and Nutrition Examination SurveySilent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphismAge and kidney function are the primary correlates of fasting plasma total homocysteine levels in non-diabetic and diabetic adults. Results from the 1999-2002 National Health and Nutrition Examination SurveyCriticial limb ischemia: epidemiologyMethylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitusHormonal regulation of cystathionine beta-synthase expression in liverHomocysteine, vitamin B12 and folate levels in premature coronary artery diseaseContemporary percutaneous treatment of infrapopliteal arterial disease: a practical approach.Acute hyperhomocysteinaemia blunts endothelial dependent and endothelial independent vasodilatation in diabetic patients.Total homocysteine and cardiovascular disease.Vitamin B12 status in metformin treated patients: systematic review.Homocysteine as a risk factor for atherosclerosis.Effect of lipopenic and hypotensive treatment on homocysteine levels in type 2 diabetics.Plasma total homocysteine and macrovascular complications are associated with food and nutrient intake in patients with Type II diabetes mellitusClinical relevance of hyperhomocysteinaemia in atherothrombotic disease.The genetics of vascular complications in diabetes mellitus.Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.Association of tagging SNPs in the MTHFR gene with risk of type 2 diabetes mellitus and serum homocysteine levels in a Chinese populationSynergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempolHyperhomocysteinaemia in Behçet's DiseasePeripheral arterial disease--epidemiological aspects.Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis.Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.Homocysteine and blood pressure.Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approachAntibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis.The metabolic syndrome: an emerging risk state for cardiovascular disease.Homocysteine levels in women with a history of gestational diabetes mellitus.MTHFR (Ala 222 Val) polymorphism and AMI in patients with type II diabetes mellitus.Homocysteine and vascular disease in diabetes: a double hit?No Evidence of a Causal Relationship between Plasma Homocysteine and Type 2 Diabetes: A Mendelian Randomization Study.Sulfur as a signaling nutrient through hydrogen sulfide.Homocysteine metabolism in ZDF (type 2) diabetic rats.Effect of zinc supplementation on serum homocysteine in type 2 diabetic patients with microalbuminuriaIdentification and management of polyvascular disease in patients with noncardioembolic ischaemic stroke.Study of Vitamin B12 deficiency and peripheral neuropathy in metformin-treated early Type 2 diabetes mellitusDoes the MTHFR C677T gene polymorphism indicate cardiovascular disease risk in type 2 diabetes mellitus patients?
P2860
Q22250962-89E1BACE-D661-49E2-8974-CB414000B0CDQ24791309-01F77F6C-A6E4-4CE3-85B6-066E6103C993Q24791545-A7504C4E-A10B-4A5F-82C8-9ED06356DF59Q24798595-0E84E874-CA93-440F-A1D5-E76180E03498Q24800332-FD7CB325-58C2-4637-A1AA-A72E22F427EBQ24814535-F86DBFFD-A573-4926-8B39-67D1BF612859Q27026881-82039543-2B85-4F98-9F40-380D709336A2Q28274776-588B274D-414C-4CF0-9870-F71017CF71D8Q28581820-0AE0F41E-EEDD-4D92-BEDC-7AC518E57558Q30827302-A5B7F499-448F-4894-AE80-16C5888F4A52Q33285698-3E979360-45F1-45A8-BD52-A4A2E00E4EB3Q33578918-983FFE32-FDC5-4810-8559-6111B7CAA5EBQ33785883-E26E9D4F-5364-4273-A655-AD300D9F47EDQ33799982-00BDEE4A-70B5-40A6-978A-AD62D791FAF3Q33834875-BA55B0FB-DFF8-4F53-938C-153BB2DB9620Q33888305-4781EAAC-1108-4696-8569-DD64D98BF821Q33901373-82B4FC8A-B913-48CC-A920-86B0DF8FE185Q33955167-E164D258-B791-49A2-ACC4-C6E0AA2AAB3DQ33995879-4197B045-C399-46B9-9F50-F9ACA3CB00CEQ34038098-8CB22CEC-DD63-4786-A9FA-F89195FA8A04Q34073375-F25B9B4C-102F-4D87-9B4E-3281401DF152Q34149341-AC5AE581-0620-42C9-89A8-373E21328D00Q34423885-849B17CE-8F1F-4423-88A3-0E86EEB4189CQ34492461-A6EA7DCC-9AD9-4726-A769-6394DCFFDC0DQ34545440-81C12ABB-4B39-42B3-B74A-5488B2002A37Q34577250-E160E84C-39EA-48E5-BA27-9EE1F9EA3585Q35046487-F43C3784-F7D9-4489-AF3D-8A29D7704381Q35062755-2C954A90-74F7-4887-B266-75A1F9C7D456Q35637080-F928CDC3-98A2-47D2-AF8D-D2EAD84EC0C7Q35824621-69BB62F4-EB16-43A1-81DE-AEC1DBCD3E95Q36217752-10A80AB0-FDAB-4DFD-9AE9-ABA77405F68DQ36263417-9717B4E7-2B5C-4A2F-95AD-CF65585D0241Q36273292-BA49C907-8D23-4E1B-A0BF-631AE8C8157EQ36351144-26C87D2C-87A1-4A68-8318-300267232C3BQ36384782-79979101-FD99-4C49-B6C3-F4ABC5A540D2Q36731967-A77D46B0-C112-43C8-8743-0498424FB7DDQ37267494-48FDB8D6-FC4D-4D03-BD9D-447D621F470DQ37277220-149E051D-5CED-4B3B-8542-2C3EFF76266EQ37292051-0C58166A-084C-4A1B-B6A6-1272500A9079Q37680631-487FF2DB-A3B5-490E-8B13-376C46F43FF4
P2860
Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Hyperhomocysteinemia is associ ...... tus: a population-based study.
@en
Hyperhomocysteinemia is associ ...... tus: a population-based study.
@nl
type
label
Hyperhomocysteinemia is associ ...... tus: a population-based study.
@en
Hyperhomocysteinemia is associ ...... tus: a population-based study.
@nl
prefLabel
Hyperhomocysteinemia is associ ...... tus: a population-based study.
@en
Hyperhomocysteinemia is associ ...... tus: a population-based study.
@nl
P2093
P50
P356
P1476
Hyperhomocysteinemia is associ ...... tus: a population-based study.
@en
P2093
P304
P356
10.1161/01.ATV.18.1.133
P407
P577
1998-01-01T00:00:00Z